Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Clin Radiol ; 71(8): 796-806, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27221526

RESUMEN

The practice of contrast-enhanced magnetic resonance angiography (CEMRA) has changed significantly in the span of a decade. Concerns regarding gadolinium (Gd)-associated nephrogenic systemic fibrosis in those with severely impaired renal function spurred developments in low-dose CEMRA and non-contrast MRA as well as efforts to seek alternative MR contrast agents. Originally developed for MR imaging use, ferumoxytol (an ultra-small superparamagnetic iron oxide nanoparticle), is currently approved by the US Food and Drug Administration for the treatment of iron deficiency anaemia in adults with renal disease. Since its clinical availability in 2009, there has been rising interest in the scientific and clinical use of ferumoxytol as an MR contrast agent. The unique physicochemical and pharmacokinetic properties of ferumoxytol, including its long intravascular half-life and high r1 relaxivity, support a spectrum of MRI applications beyond the scope of Gd-based contrast agents. Moreover, whereas Gd is not found in biological systems, iron is essential for normal metabolism, and nutritional iron deficiency poses major public health challenges worldwide. Once the carbohydrate shell of ferumoxytol is degraded, the elemental iron at its core is incorporated into the reticuloendothelial system. These considerations position ferumoxytol as a potential game changer in the field of CEMRA and MRI. In this paper, we aim to summarise our experience with the cardiovascular applications of ferumoxytol and provide a brief synopsis of ongoing investigations on ferumoxytol-enhanced MR applications.


Asunto(s)
Enfermedades Cardiovasculares/diagnóstico por imagen , Enfermedades Cardiovasculares/metabolismo , Óxido Ferrosoférrico/farmacocinética , Aumento de la Imagen/métodos , Angiografía por Resonancia Magnética/métodos , Medios de Contraste/efectos adversos , Medios de Contraste/farmacocinética , Óxido Ferrosoférrico/efectos adversos , Humanos , Angiografía por Resonancia Magnética/efectos adversos , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Distribución Tisular
2.
J Neurol Sci ; 234(1-2): 67-71, 2005 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-15946690

RESUMEN

OBJECTIVES: To characterize the clinical, demographic and epidemiological features of MS patients from the only specialised MS centre in Iraq. METHODS: Data for consecutive Iraqi MS patients attending the Baghdad Multidiscipline MS Clinic between 2000 and 2002 who fulfilled Poser et al. criteria for clinically definite (CD) and clinically probable (CP) MS were reviewed. RESULTS: We identified a total of 300 MS patients (164 females, 54.7%; 136 males, 45.3%) with a mean age of onset being 29.2+/-7.8 years and the duration being 8.6+/-5.9 years. According to the year of clinical onset of MS, a progressive increase in cases in the last two decades and a trend towards more females was noted. Initial symptom was reported as motor in 31.7%, sensory in 28.3%, optic nerve in 24% and brainstem or cerebellar in 22.3% of patients. The course was relapsing-remitting in 199 (66.3%) patients, secondary progressive in 56 (18.7%) and primary progressive (PP) in 45 (15%) patients. CONCLUSIONS: MS is not rare in Iraq; its demographic and clinical data were, in general, similar to those reported in Caucasian populations. There was some evidence for North-South gradient and a possible increasing incidence characterized by an increase in female preponderance during the last 2 decades.


Asunto(s)
Evaluación de la Discapacidad , Esclerosis Múltiple/epidemiología , Esclerosis Múltiple/fisiopatología , Adulto , Distribución por Edad , Edad de Inicio , Demografía , Femenino , Humanos , Irak/epidemiología , Imagen por Resonancia Magnética/métodos , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/clasificación , Esclerosis Múltiple/patología , Prevalencia , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Factores Sexuales
3.
Arch Surg ; 131(9): 949-52; discussion 952-3, 1996 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8790180

RESUMEN

OBJECTIVE: To evaluate the contribution of aortography in the management of stable patients with transmediastinal gunshot wounds. DESIGN: Retrospective review of clinical records. SETTING: Level I urban trauma center. PATIENTS: Forty-three patients with aortic or esophageal gunshot injuries. INTERVENTIONS: Patients who were stable after initial resuscitation underwent aortography followed by esophagography. MAIN OUTCOME MEASURES: Hemodynamic status on admission, time devoted to diagnostic workup, surgical (or autopsy) findings, morbidity, and mortality. RESULTS: There were 24 esophageal injuries and 20 aortic injuries. Patients with aortic injuries were less often stable for aortography (10% vs 42%; P = .02), and fewer of them survived (15% vs 58%; P = .01). In no patient was the aortic injury initially detected by aortography. Stable patients with esophageal injuries experienced an average 11-hour interval between injury and surgery (nearly 3 hours attributable to aortography). CONCLUSION: Esophageal evaluation should precede aortography in the workup of stable patients with transmediastinal gunshot wounds.


Asunto(s)
Aorta/lesiones , Esófago/diagnóstico por imagen , Esófago/lesiones , Mediastino/lesiones , Heridas por Arma de Fuego , Adolescente , Adulto , Anciano , Aortografía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
4.
East Mediterr Health J ; 8(4-5): 515-20, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-15603033

RESUMEN

We compared the efficacy of misoprostol with that of prostaglandin E2 in cervical ripening and labour induction. Thus 238 women with rupture of membranes beyond 36 weeks gestation without labour were randomized to receive 50 microg misoprostol vaginal gel or 5 mg of prostaglandin E2 gel. Bishop score was evaluated before drug application and 6 hours later. Clinical data and perinatal outcome were recorded. Mean time from induction to delivery and the need for oxytocin were significantly less in the misoprostol group. There were no significant differences in spontaneous labour rate, type of delivery and perinatal outcome. It is concluded that intravaginal misoprostol is safe and more effective than prostaglandin E2 for preinduction cervical ripening in premature rupture of membranes beyond 36 weeks gestation.


Asunto(s)
Rotura Prematura de Membranas Fetales/tratamiento farmacológico , Trabajo de Parto Inducido/métodos , Misoprostol/administración & dosificación , Oxitócicos/administración & dosificación , Administración Intravaginal , Maduración Cervical/efectos de los fármacos , Parto Obstétrico/métodos , Parto Obstétrico/estadística & datos numéricos , Dinoprostona/administración & dosificación , Dinoprostona/efectos adversos , Dinoprostona/farmacología , Femenino , Sufrimiento Fetal/inducido químicamente , Sufrimiento Fetal/diagnóstico , Geles , Humanos , Trabajo de Parto Inducido/efectos adversos , Misoprostol/efectos adversos , Misoprostol/farmacología , Oxitócicos/efectos adversos , Oxitócicos/farmacología , Selección de Paciente , Embarazo , Resultado del Embarazo/epidemiología , Tercer Trimestre del Embarazo , Seguridad , Taquicardia/inducido químicamente , Taquicardia/diagnóstico , Factores de Tiempo , Resultado del Tratamiento , Cremas, Espumas y Geles Vaginales
5.
Neurosciences (Riyadh) ; 8(3): 177-83, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23649115

RESUMEN

OBJECTIVE: Multiple sclerosis (MS) is a demyelinating disorder of the central nervous system. Autonomic dysfunction in MS patients may cause significant morbidity. The aim of this controlled cross sectional study was to investigate the prevalence, pattern and severity of autonomic dysfunction in Iraqi MS patients and to correlate them with patient`s age, disease course, duration and severity. METHODS: Fifty-five patients with clinically definite MS according to Poser`s criteria attending Baghdad MS clinic at Baghdad Teaching Hospital were studied between July 2000 and August 2001. Each patient was assessed according to a detailed protocol paper. Expanded disability status scale was used to assess the severity of the disease. The severity of autonomic symptoms was classified according to autonomic nervous system disability scale (ANSDS). Five standardized autonomic cardiovascular (Ewing) tests were performed for every patient which included: heart rate responses to deep breathing, Valsalva maneuver and standing, and blood pressure responses to standing and sustained hand grip. Forty matched healthy subjects were studied as a control group who were assessed with the same protocol paper, ANSDS and Ewing tests. RESULTS: Autonomic symptoms were significantly more prevalent in MS patients than in the controls. Cardiovascular, urinary and gastrointestinal symptoms were highly prevalent. The severity of the different autonomic symptoms as assessed by ANSDS, were higher in the patients than the controls. All 5 Ewing tests in the patients showed highly significant abnormal results as compared to those of the control. Definite parasympathetic derangement was found in 45.5% of the patients while combined sympathetic and parasympathetic derangements were found in 34.5% of the patients. There were significant correlations between the finding of definite autonomic dysfunctions and the age of the patients at the time of assessment and the duration of the disease. CONCLUSION: Autonomic dysfunctions as assessed by a formal interview, ANSDS and by Ewing tests were common in Iraqi MS patients. Careful attention to autonomic disturbances should be considered in the routine evaluation of MS patients which might help in improving their quality of life.

7.
(East. Mediterr. health j).
en Inglés | WHOLIS | ID: who-119194

RESUMEN

We compared the efficacy of misoprostol with that of prostaglandin E2 in cervical ripening and labour induction. Thus 238 women with rupture of membranes beyond 36 weeks gestation without labour were randomized to receive 50 microg misoprostol vaginal gel or 5 mg of prostaglandin E2 gel. Bishop score was evaluated before drug application and 6 hours later. Clinical data and perinatal outcome were recorded. Mean time from induction to delivery and the need for oxytocin were significantly less in the misoprostol group. There were no significant differences in spontaneous labour rate, type of delivery and perinatal outcome. It is concluded that intravaginal misoprostol is safe and more effective than prostaglandin E2 for preinduction cervical ripening in premature rupture of membranes beyond 36 weeks gestation


Asunto(s)
Administración Intravaginal , Maduración Cervical , Parto Obstétrico , Dinoprostona , Sufrimiento Fetal , Trabajo de Parto Inducido , Misoprostol , Oxitócicos , Embarazo , Taquicardia , Cremas, Espumas y Geles Vaginales , Rotura Prematura de Membranas Fetales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA